When will the new hepatitis B drug TAF be launched? At the press conference, Gilead did not announce a specific launch time, but based on previous launch times of new drugs, it is expected that next month, that is, January 2019, hepatitis B patients will be able to go to the pharmacies of major hospitals or major pharmacies across the country. You can buy new medicines.
At the same time, because the drug concentration of TAF in the blood decreases, the kidney side effects and bone safety factor for hepatitis B patients who need to take long-term medication have been greatly improved. In addition, hepatitis B patients need to take medicine for a long time, and there was a great risk of drug resistance in the past. However, judging from the domestic phase 3 clinical study of TAF, there was no case of drug-resistant patients during the 96-week treatment period. However, referring to the new drugs previously launched, the domestic price of TAF will not be cheap, so patients may still have to continue to purchase Indian TAF generic drugs.